Treatment as prevention: The breaking of taboos is required in the fight against hepatitis C among people who inject drugs

Authors

  • Philip Bruggmann M.D.

    Corresponding author
    1. Arud Centers of Addiction Medicine, Zürich, Switzerland
    • Address reprint requests to: Philip Bruggmann, M.D., Arud Centres for Addiction Medicine, Konradstrasse 32, 8005 Zürich, Switzerland. E-mail: p.bruggmann@arud.ch; fax: +058-360-50-19.

    Search for more papers by this author

  • Potential conflict of interest: The author has served as advisor/speaker for and has received project and research grants from Roche, MSD, Janssen, Abbott, Gilead, Viif and Bristol-Myers Squibb.

  • See Article on Page 1598

No abstract is available for this article.

Ancillary